HIV Treatment and Prevention Agents Presentation Vaccines 
Pharmacy Times
JULY 16, 2025
Tarlatamab established a new standard for relapsed SCLC, with improved survival and easier administration, enhancing treatment accessibility. Zanubrutinib demonstrated sustained efficacy in CLL with del(17p), emphasizing the importance of BTK inhibitors in high-risk hematologic malignancies.
Pharmacy Times
AUGUST 12, 2025
Pharmacists are key in advising on self-care, prevention, and OTC product selection for mild to moderate contact dermatitis. Pharmacists are key in advising on self-care, prevention, and OTC product selection for mild to moderate contact dermatitis. SHOW MORE Prompt identification and appropriate clinical intervention are critical.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 19, 2025
Malesker, PharmD, FCCP, FCCM, FASHP, BCPS +1 More Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action. Jansen, PharmD Candidate , Mark A.
Pharmacy Times
AUGUST 2, 2025
These technologies prevent the risk of both hypo- and hyperglycemic episodes, facilitating safer fasting. The guidance is updated every 5 years, with the most recent update published in May 2025. Monitoring technology is valuable to assess glycemic control and enable timely interventions in T1D patients.
Pharmacy Times
JUNE 16, 2025
SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Transportation barriers, as a health-related social need, significantly impact FN rates in chemotherapy patients. Febrile neutropenia (FN) remains a serious and common complication of chemotherapy.
Pharmacy Times
JUNE 23, 2025
The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans.
Pharmacy Times
JULY 21, 2025
Cardiovascular disease risks in HIV patients have evolved with ART, requiring preventive measures like statins and cardiovascular risk scores for effective management. Healthy aging in HIV patients involves addressing accelerated aging, multimorbidity, and geriatric syndromes, emphasizing functional ability and quality of life.
Expert insights. Personalized for you.
Let's personalize your content